Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage. Azad TD, Wu RJ, Anderson KE, Darden M, et al. Osteoporos Int 2024 Nov 21. doi: 10.1007/s00198-024-07318.

Read + Share

Amedeo Smart

Independent Medical Education

Azad TD, Wu RJ, Anderson KE, Darden M, et al. Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage. Osteoporos Int 2024 Nov 21. doi: 10.1007/s00198-024-07318.
PMID: 39570337